AAPL282.45-1.33 (-0.47%) ▼|ABBV255.01+1.66 (+0.66%) ▲|ABT94.36+0.24 (+0.25%) ▲|ACN126.51-2.47 (-1.92%) ▼|ADBE205.77+3.04 (+1.50%) ▲|AMAT696.79+69.95 (+11.16%) ▲|AMD523.43+1.85 (+0.35%) ▲|AMGN359.60+1.27 (+0.35%) ▲|AMT169.37-6.22 (-3.54%) ▼|AMZN241.47+8.78 (+3.77%) ▲|AVGO370.48+5.46 (+1.50%) ▲|AXP340.57+0.21 (+0.06%) ▲|BA214.78-2.48 (-1.14%) ▼|BAC58.14+0.26 (+0.44%) ▲|BKNG184.63+3.17 (+1.74%) ▲|BLK949.75-14.96 (-1.55%) ▼|BMY57.68+0.16 (+0.27%) ▲|BNY144.77+1.21 (+0.84%) ▲|BRK-B497.68-0.98 (-0.20%) ▼|C142.97+1.21 (+0.85%) ▲|CAT1,019.18+21.71 (+2.18%) ▲|CL91.52-0.55 (-0.60%) ▼|CMCSA24.78+1.61 (+6.93%) ▲|COF202.53-1.47 (-0.72%) ▼|COP104.59-1.37 (-1.29%) ▼|COST954.12+1.58 (+0.17%) ▲|CRM159.10+0.73 (+0.46%) ▲|CSCO117.49+3.72 (+3.27%) ▲|CVS104.22-0.12 (-0.12%) ▼|CVX168.87-2.19 (-1.28%) ▼|DE614.43+1.19 (+0.19%) ▲|DHR193.13-3.07 (-1.56%) ▼|DIS99.10+0.31 (+0.31%) ▲|DUK128.02-0.39 (-0.30%) ▼|EMR142.25-1.24 (-0.86%) ▼|FDX323.15+4.62 (+1.45%) ▲|GD350.29+3.58 (+1.03%) ▲|GE373.97+4.97 (+1.35%) ▲|GEV1,085.90+40.73 (+3.90%) ▲|GILD126.13-1.75 (-1.37%) ▼|GM77.57-0.53 (-0.68%) ▼|GOOG349.67+14.98 (+4.47%) ▲|GOOGL351.62+14.23 (+4.22%) ▲|GS1,022.97+3.36 (+0.33%) ▲|HD347.86-1.00 (-0.29%) ▼|HON237.93-5.49 (-2.25%) ▼|IBM274.26+2.63 (+0.97%) ▲|INTC125.84-2.48 (-1.93%) ▼|INTU268.35+0.63 (+0.23%) ▲|ISRG405.81+1.54 (+0.38%) ▲|JNJ255.38+0.72 (+0.28%) ▲|JPM331.47+2.42 (+0.74%) ▲|KO82.91+0.28 (+0.34%) ▲|LIN508.81-10.81 (-2.08%) ▼|LLY1,210.75+2.63 (+0.22%) ▲|LMT504.69-2.71 (-0.53%) ▼|LOW220.25-2.23 (-1.00%) ▼|LRCX409.96+30.87 (+8.14%) ▲|MA510.18+11.16 (+2.24%) ▲|MCD266.65-3.11 (-1.15%) ▼|MDLZ59.88-0.91 (-1.50%) ▼|MDT81.46+0.48 (+0.59%) ▲|META564.60+14.35 (+2.61%) ▲|MMM163.85-0.17 (-0.10%) ▼|MO73.38-0.41 (-0.56%) ▼|MRK128.99+0.33 (+0.25%) ▲|MS213.25+1.22 (+0.58%) ▲|MSFT371.38-1.59 (-0.43%) ▼|MU1,093.91-38.42 (-3.39%) ▼|NEE87.54-1.03 (-1.16%) ▼|NFLX75.19+1.38 (+1.87%) ▲|NKE41.23+0.48 (+1.17%) ▲|NOW100.79+2.45 (+2.49%) ▲|NVDA193.91+1.38 (+0.72%) ▲|ORCL149.04+0.51 (+0.34%) ▲|PEP139.07-2.32 (-1.64%) ▼|PFE24.17-0.12 (-0.49%) ▼|PG147.47-1.55 (-1.04%) ▼|PLTR115.77+2.84 (+2.51%) ▲|PM180.45-0.32 (-0.18%) ▼|QCOM191.79+2.40 (+1.27%) ▲|RTX188.03+0.04 (+0.02%) ▲|SBUX103.23-1.37 (-1.31%) ▼|SCHW90.99+0.32 (+0.35%) ▲|SO96.86-0.31 (-0.31%) ▼|SPG225.53-1.36 (-0.60%) ▼|T21.52-1.21 (-5.30%) ▼|TMO503.37-9.67 (-1.88%) ▼|TMUS174.00-8.68 (-4.75%) ▼|TSLA399.97+20.26 (+5.34%) ▲|TXN286.92+1.50 (+0.52%) ▲|UBER75.58-0.62 (-0.81%) ▼|UNH418.00-9.89 (-2.31%) ▼|UNP271.49+3.14 (+1.17%) ▲|UPS107.24-0.91 (-0.84%) ▼|USB61.48+0.57 (+0.93%) ▲|V341.64+5.41 (+1.61%) ▲|VZ43.30-3.25 (-6.97%) ▼|WFC84.27+0.41 (+0.49%) ▲|WMT114.68-1.01 (-0.87%) ▼|XOM135.76-0.78 (-0.57%) ▼|AAPL282.45-1.33 (-0.47%) ▼|ABBV255.01+1.66 (+0.66%) ▲|ABT94.36+0.24 (+0.25%) ▲|ACN126.51-2.47 (-1.92%) ▼|ADBE205.77+3.04 (+1.50%) ▲|AMAT696.79+69.95 (+11.16%) ▲|AMD523.43+1.85 (+0.35%) ▲|AMGN359.60+1.27 (+0.35%) ▲|AMT169.37-6.22 (-3.54%) ▼|AMZN241.47+8.78 (+3.77%) ▲|AVGO370.48+5.46 (+1.50%) ▲|AXP340.57+0.21 (+0.06%) ▲|BA214.78-2.48 (-1.14%) ▼|BAC58.14+0.26 (+0.44%) ▲|BKNG184.63+3.17 (+1.74%) ▲|BLK949.75-14.96 (-1.55%) ▼|BMY57.68+0.16 (+0.27%) ▲|BNY144.77+1.21 (+0.84%) ▲|BRK-B497.68-0.98 (-0.20%) ▼|C142.97+1.21 (+0.85%) ▲|CAT1,019.18+21.71 (+2.18%) ▲|CL91.52-0.55 (-0.60%) ▼|CMCSA24.78+1.61 (+6.93%) ▲|COF202.53-1.47 (-0.72%) ▼|COP104.59-1.37 (-1.29%) ▼|COST954.12+1.58 (+0.17%) ▲|CRM159.10+0.73 (+0.46%) ▲|CSCO117.49+3.72 (+3.27%) ▲|CVS104.22-0.12 (-0.12%) ▼|CVX168.87-2.19 (-1.28%) ▼|DE614.43+1.19 (+0.19%) ▲|DHR193.13-3.07 (-1.56%) ▼|DIS99.10+0.31 (+0.31%) ▲|DUK128.02-0.39 (-0.30%) ▼|EMR142.25-1.24 (-0.86%) ▼|FDX323.15+4.62 (+1.45%) ▲|GD350.29+3.58 (+1.03%) ▲|GE373.97+4.97 (+1.35%) ▲|GEV1,085.90+40.73 (+3.90%) ▲|GILD126.13-1.75 (-1.37%) ▼|GM77.57-0.53 (-0.68%) ▼|GOOG349.67+14.98 (+4.47%) ▲|GOOGL351.62+14.23 (+4.22%) ▲|GS1,022.97+3.36 (+0.33%) ▲|HD347.86-1.00 (-0.29%) ▼|HON237.93-5.49 (-2.25%) ▼|IBM274.26+2.63 (+0.97%) ▲|INTC125.84-2.48 (-1.93%) ▼|INTU268.35+0.63 (+0.23%) ▲|ISRG405.81+1.54 (+0.38%) ▲|JNJ255.38+0.72 (+0.28%) ▲|JPM331.47+2.42 (+0.74%) ▲|KO82.91+0.28 (+0.34%) ▲|LIN508.81-10.81 (-2.08%) ▼|LLY1,210.75+2.63 (+0.22%) ▲|LMT504.69-2.71 (-0.53%) ▼|LOW220.25-2.23 (-1.00%) ▼|LRCX409.96+30.87 (+8.14%) ▲|MA510.18+11.16 (+2.24%) ▲|MCD266.65-3.11 (-1.15%) ▼|MDLZ59.88-0.91 (-1.50%) ▼|MDT81.46+0.48 (+0.59%) ▲|META564.60+14.35 (+2.61%) ▲|MMM163.85-0.17 (-0.10%) ▼|MO73.38-0.41 (-0.56%) ▼|MRK128.99+0.33 (+0.25%) ▲|MS213.25+1.22 (+0.58%) ▲|MSFT371.38-1.59 (-0.43%) ▼|MU1,093.91-38.42 (-3.39%) ▼|NEE87.54-1.03 (-1.16%) ▼|NFLX75.19+1.38 (+1.87%) ▲|NKE41.23+0.48 (+1.17%) ▲|NOW100.79+2.45 (+2.49%) ▲|NVDA193.91+1.38 (+0.72%) ▲|ORCL149.04+0.51 (+0.34%) ▲|PEP139.07-2.32 (-1.64%) ▼|PFE24.17-0.12 (-0.49%) ▼|PG147.47-1.55 (-1.04%) ▼|PLTR115.77+2.84 (+2.51%) ▲|PM180.45-0.32 (-0.18%) ▼|QCOM191.79+2.40 (+1.27%) ▲|RTX188.03+0.04 (+0.02%) ▲|SBUX103.23-1.37 (-1.31%) ▼|SCHW90.99+0.32 (+0.35%) ▲|SO96.86-0.31 (-0.31%) ▼|SPG225.53-1.36 (-0.60%) ▼|T21.52-1.21 (-5.30%) ▼|TMO503.37-9.67 (-1.88%) ▼|TMUS174.00-8.68 (-4.75%) ▼|TSLA399.97+20.26 (+5.34%) ▲|TXN286.92+1.50 (+0.52%) ▲|UBER75.58-0.62 (-0.81%) ▼|UNH418.00-9.89 (-2.31%) ▼|UNP271.49+3.14 (+1.17%) ▲|UPS107.24-0.91 (-0.84%) ▼|USB61.48+0.57 (+0.93%) ▲|V341.64+5.41 (+1.61%) ▲|VZ43.30-3.25 (-6.97%) ▼|WFC84.27+0.41 (+0.49%) ▲|WMT114.68-1.01 (-0.87%) ▼|XOM135.76-0.78 (-0.57%) ▼|
27.6 C
New York
Monday, June 29, 2026

Tag: medical

newssourceFORcompanyinformationcontent1releasesmarket

Omniscient and The Jacobs Institute, Inc. Announce Strategic Partnership to Pioneer Clinical Connectomics

Omniscient and The Jacobs Institute launch Connectomics Innovation Program to advance stroke recovery and neurologic care with AI-enabled software.

Minnesota Medical Technologies Announces FDA 510(k) Clearance for its Fecal Incontinence Device

STEWARTVILLE, Minn., July 24, 2025 /PRNewswire/ -- Minnesota Medical Technologies, today announced that it received FDA 510(k) clearance for its fecal incontinence device ("StaySure(™)"). ...

Knee Replacement Surgery Market worth $16.17 billion in 2030 with 6.1% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 24, 2025 /PRNewswire/ -- The global Knee Replacement Surgery Market, valued at US$10.86 billion in 2023 stood at US$12.00 billion in 2025...

HealthSure 3X Launches Virtual In-Home Medical Services with Improved Access to Quality Care

NEWARK, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- HealthSure 3X, an online health solutions company headquartered in New Jersey, has introduced a fully integrated platform where patients can avail themselves of licensed healthcare professionals at home using virtual in-home medical care. This method caters to growing needs for accessible and flexible healthcare while upholding professional standards and patient safety.

IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma

The presentation will include data from over 90 patients in both the plaque brachytherapy and enucleation-eligible cohortsDarovasertib has received U.S. FDA Breakthrough Therapy Designation...

PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications

Study reveals millions of previously unknown variants and genomic sequences from underrepresented populations 
Study reveals millions of previously unknown variants and genomic sequences from underrepresented populations

NANO Nuclear Joins the Canadian Nuclear Association to Support the Adoption of Next-Generation Advanced Nuclear Energy Technologies in Canada

New York, N.Y., July 24, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that it has joined the Canadian Nuclear Association (CNA), the leading Canadian nuclear industry advocacy group since 1960.

Cognizant’s AI Lab Records 59th U.S. Patent, Continuing to Generate AI Breakthroughs

In 2025, the Lab has yielded two new U.S. Granted Patents, open-sourced a key AI development platform, and earned a Gold Award from GECCO...

Matchpoint Therapeutics Announces Exclusive Option and License Agreement with Novartis to Develop Oral Inhibitors for Multiple Inflammatory Diseases

Matchpoint Therapeutics Announces Exclusive Option and License Agreement with Novartis to Develop Oral Inhibitors for Multiple Inflammatory Diseases

MediciNova Provides Enrollment Update for Ongoing ALS and Hypertriglyceridemia Clinical Trials

MN-166 COMBAT ALS trial down to single digit required enrollment while MN-001 hypertriglyceridemia trial in type 2 diabetes patients requires final two patients 
MN-166 COMBAT ALS trial down to single digit required enrollment while MN-001 hypertriglyceridemia trial in type 2 diabetes patients requires final two patients

Aicuris Enrolled Last Participant in Pivotal Trial with Pritelivir to Treat Refractory Herpes Simplex Infection in Immunocompromised Patients

Wuppertal, Germany, July 24, 2025 - Aicuris Anti-infective Cures AG today announced the completion of patient enrollment in its pivotal Phase 3 trial, PRIOH-1, evaluating pritelivir for the treatment of refractory and/or treatment resistant herpes simplex virus (HSV) infections in immunocompromised patients. The company’s lead candidate is a small molecule specifically inhibiting the viral helicase-primase complex, which represents a novel mechanism of action distinct from current HSV therapies.

Australian Life Sciences Venture Capital firm Brandon Capital announces Fund Six final close totalling over A$439m

MELBOURNE, Australia, July 24, 2025 (GLOBE NEWSWIRE) -- Brandon Capital, Australasia’s leading life sciences venture capital firm, today announced the final close of its sixth fund at A$439 million.

Half-year results 2025: Consistent execution, improving growth foundations

[Ad hoc announcement pursuant to Art. 53 LR]

Magnolia Pearl Launches Philanthropy-Driven Resale Platform, Donating Up to 100% of Proceeds to Charity

MALIBU, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Magnolia Pearl, the international fashion brand known for its distinct, artisan-crafted garments, has announced the official launch of Magnolia Pearl Trade, a resale platform designed to extend the life cycle of its products while directing proceeds to charitable organizations.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMedical

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers